Testing Viomes Personalized Nutrition Program to Lower Blood Sugar HbA1c in Adults with Diabetes

What this Trial Is About

This research aims to evaluate the effectiveness of Viomes Precision Nutrition Program VPNP in lowering HbA1c levels in adults with diabetes. This randomized, placebo-controlled trial recruits participants with HbA1c levels between 6.5% and 8.9% to compare personalized nutritional recommendations and supplements against placebo. The study focuses on assessing how these interventions may impact blood sugar control over approximately 90 days. Participants are randomly assigned to either the VPNP group or a placebo group. At the start, they complete online questionnaires and provide samples of blood, stool, and saliva through at-home collection kits sent back to Viome for analysis. After analysis, those in the VPNP group receive tailored dietary advice and personalized supplements, while the placebo group receives inactive capsules. Both groups follow their assigned plans for 90 days, after which they repeat questionnaires and sample collections for comparison. Throughout the study, participants complete assessments including blood tests and questionnaires about health and mood. Researchers monitor HbA1c levels, fasting insulin, BMI, waist-to-hip ratio, cholesterol, cardiovascular risk, mental health scores, and species prevalence in collected samples. Participants may use a mobile app to assist with the program and must be able to visit a diagnostic center for some tests. The total participation time is about three months, with data collected at the start and end of the period to evaluate changes.

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c